ChemSpider 2D Image | TW3589990 | C21H35N3O7

TW3589990

  • Molecular FormulaC21H35N3O7
  • Average mass441.518 Da
  • Monoisotopic mass441.247498 Da
  • ChemSpider ID4514932
  • defined stereocentres - 3 of 3 defined stereocentres


More details:






Validated by Experts, Validated by Users, Non-Validated, Removed by Users

(2S)-1-[(2S)-6-Amino-2-{[(1S)-1-carboxy-3-phenylpropyl]amino}hexanoyl]pyrrolidine-2-carboxylic acid dihydrate [ACD/IUPAC Name]
(S)-1-[N2-(1-Carboxy-3-phenylpropyl)-lysyl-proline dihydrate
83915-83-7 [RN]
Lisinopril Dihydrate
Lisinopril diydrate
Lisinopril for peak identification
Lisinopril for system suitability A
L-Proline, N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-, hydrate (1:2) [ACD/Index Name]
MFCD01698825 [MDL number]
N2-[(1S)-1-Carboxy-3-phenylpropyl]-L-lysyl-L-prolindihydrat [German] [ACD/IUPAC Name]
More...

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

E7199S1YWR [DBID]
MK-521 [DBID]
CHEBI:6503 [DBID]
D00362 [DBID]
HSDB 6852 [DBID]
LS-118900 [DBID]
NCGC00017141-01 [DBID]
Prestwick_613 [DBID]
UNII:E7199S1YWR [DBID]
UNII-E7199S1YWR [DBID]
  • Experimental Physico-chemical Properties
  • Miscellaneous
    • Target Organs:

      RAAS inhibitor;ACE inhibitor;MRP inhibitor TargetMol T0706
    • Bio Activity:

      ACE;MRP1 TargetMol T0706
      Angiogenesis;Endocrinology/ Hormones TargetMol T0706
      Angiotensin-converting Enzyme (ACE) MedChem Express HY-18206A
      Lisinopril Dihydrate is angiotensin-converting enzyme inhibitor, used in treatment of hypertension, congestive heart failure, and heart attacks. MedChem Express
      Lisinopril Dihydrate is angiotensin-converting enzyme inhibitor, used in treatment of hypertension, congestive heart failure, and heart attacks.; Target: ACE; Lisinopril is a potent, competitive inhibitor of angiotensin-converting enzyme (ACE), the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). MedChem Express HY-18206A
      Lisinopril Dihydrate is angiotensin-converting enzyme inhibitor, used in treatment of hypertension, congestive heart failure, and heart attacks.;Target: ACELisinopril is a potent, competitive inhibitor of angiotensin-converting enzyme (ACE), the enzyme responsible for the conversion of angiotensin I (ATI) to angiotensin II (ATII). ATII regulates blood pressure and is a key component of the renin-angiotensin-aldosterone system (RAAS). Lisinopril may be used to treat hypertension and symptomatic congestive heart failure, to improve survival in certain individuals following myocardial infarction, and to prevent progression of renal disease in hypertensive patients with diabetes mellitus and microalbuminuria or overt nephropathy [1, 2]. MedChem Express HY-18206A
      Metabolism/Protease MedChem Express HY-18206A
      Metabolism/Protease; MedChem Express HY-18206A

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module

No predicted properties have been calculated for this compound.

Click to predict properties on the Chemicalize site






Advertisement